Published in Cardiovascular Business Week, March 3rd, 2009
"SVS-VR on-line provider-reported data include baseline through follow-up visits to better understand long-term risks and benefits...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.